What did Pritzker pay for KabaFusion?

Pritzker acquired KabaFusion for $250.0M in 2019 (15.0x EBITDA). Target EBITDA was approximately $16.7M.

What does KabaFusion do?

KabaFusion is a pharmacy business.

What multiple did Pritzker pay for KabaFusion?

15.0x EBITDA, based on disclosed deal value of $250.0M and disclosed financials.

M&A TRANSACTION · 2019

KabaFusion acquired by Pritzker

$250.0M· 15.0x EBITDA

Target

KabaFusion

Acquirer

Pritzker

Disclosed financials at time of acquisition

Revenue

—

EBITDA

$16.7M

Deal Value

$250.0M

EV/EBITDA

15.0x

Context

This $250.0M acquisition of KabaFusion by Pritzker sits in the pharmacy sub-vertical. The 15.0x EBITDA multiple paid in 2019 can be compared against the population median for pharmacy transactions of similar size on our Pharmacy valuation hub.

Source

Data sourced from Press reporting. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own pharmacy

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the KabaFusion acquisition.

Citation: ExitValue.ai. (2019). KabaFusion acquired by Pritzker. https://exitvalue.ai/deals/kabafusion-acquired-by-pritzker-hc-2019-0155